Published in:
01-12-2021 | Metastasis | ASO Author Reflections
ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases
Authors:
Checca Bakkers, MD, Robin J. Lurvink, MD, Felice N. van Erning, PhD, Simon W. Nienhuijs, MD, PhD, Ignace H. J. T. de Hingh, MD, PhD
Published in:
Annals of Surgical Oncology
|
Issue 13/2021
Login to get access
Excerpt
Peritoneal metastases are common in colorectal cancer, occurring in 5.7% during initial diagnosis and treatment (i.e., synchronous), whereas 5.5% develop peritoneal metastases during the first 3 years of follow-up after curative resection of the primary tumor (i.e., metachronous).
1 Although the risk factors for developing synchronous and metachronous colorectal peritoneal metastases (CPM) are similar,
1 biological behavior may differ and result in a different prognosis. Therefore, the purpose of the current population-based study was to compare treatment strategies and prognosis of patients with synchronous CPM to metachronous CPM.
2 …
